Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone

JR Muppidi, TI Arnon, Y Bronevetsky, Natacha Veerapen, M Tanaka, Gurdyal Besra, JG Cyster

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Specialized B cells residing in the splenic marginal zone (MZ) continuously survey the blood for antigens and are important for immunity to systemic infections. However, the cues that uniquely attract cells to the MZ have not been defined. Previous work demonstrated that mice deficient in cannabinoid receptor 2 (CB2) have decreased numbers of MZ B cells but it has been unclear whether CB2 regulates MZ B cell development or positioning. We show that MZ B cells are highly responsive to the CB2 ligand 2-arachidonylglycerol (2-AG) and that CB2 antagonism rapidly displaces small numbers of MZ B cells to the blood. Antagonism for longer durations depletes MZ B cells from the spleen. In mice deficient in sphingosine-1-phosphate receptor function, CB2 antagonism causes MZ B cell displacement into follicles. Moreover, CB2 overexpression is sufficient to position B cells to the splenic MZ. These findings establish a role for CB2 in guiding B cells to the MZ and in preventing their loss to the blood. As a consequence of their MZ B cell deficiency, CB2-deficient mice have reduced numbers of CD1d-high B cells. We show that CB2 deficiency results in diminished humoral responses to a CD1d-restricted systemic antigen.
Original languageEnglish
Pages (from-to)1941-1948
Number of pages8
JournalThe Journal of Experimental Medicine
Volume208
Issue number10
DOIs
Publication statusPublished - 1 Sep 2011

Fingerprint

Dive into the research topics of 'Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone'. Together they form a unique fingerprint.

Cite this